Open AccessStandardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement ( ICHOM )
Author(s) -
McNamara Robert L.,
Spatz Erica S.,
Kelley Thomas A.,
Stowell Caleb J.,
Beltrame John,
Heidenreich Paul,
Tresserras Ricard,
Jernberg Tomas,
Chua Terrance,
Morgan Louise,
Panigrahi Bishnu,
Rosas Ruiz Alba,
Rumsfeld John S.,
Sadwin Lawrence,
Schoeberl Mark,
Shahian David,
Weston Clive,
Yeh Robert,
Lewin Jack
Publication year - 2015
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.115.001767
Subject(s) - medicine , coronary artery disease , angina , myocardial infarction , canadian cardiovascular society , percutaneous coronary intervention , acute coronary syndrome , chest pain , comorbidity , physical therapy , emergency medicine , intensive care medicine
Background Coronary artery disease (CAD) outcomes consistently improve when they are routinely measured and provided back to physicians and hospitals. However, few centers around the world systematically track outcomes, and no global standards exist. Furthermore, patient‐centered outcomes and longitudinal outcomes are under‐represented in current assessments. Methods and Results The nonprofit International Consortium for Health Outcomes Measurement (ICHOM) convened an international Working Group to define a consensus standard set of outcome measures and risk factors for tracking, comparing, and improving the outcomes of CAD care. Members were drawn from 4 continents and 6 countries. Using a modified Delphi method, the ICHOM Working Group defined who should be tracked, what should be measured, and when such measurements should be performed. The ICHOM CAD consensus measures were designed to be relevant for all patients diagnosed with CAD, including those with acute myocardial infarction, angina, and asymptomatic CAD. Thirteen specific outcomes were chosen, including acute complications occurring within 30 days of acute myocardial infarction, coronary artery bypass grafting surgery, or percutaneous coronary intervention; and longitudinal outcomes for up to 5 years for patient‐reported health status (Seattle Angina Questionnaire [SAQ‐7], elements of Rose Dyspnea Score, and Patient Health Questionnaire [PHQ‐2]), cardiovascular hospital admissions, cardiovascular procedures, renal failure, and mortality. Baseline demographic, cardiovascular disease, and comorbidity information is included to improve the interpretability of comparisons. Conclusions ICHOM recommends that this set of outcomes and other patient information be measured for all patients with CAD.